ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bayer close to glyphosate settlement worth $8-10 billion: German business daily
June 24, 2020The settlement is over claims that its glyphosate-based Roundup weedkiller causes cancer. -
Bayer faces second investor reckoning over glyphosate litigation
April 29, 2020Criticism from investors at this year’s annual shareholders’ meeting – held in a virtual format with gatherings banned due to the coronavirus – will likely be less scathing than it was in 2019. -
EPA Will Not Approve Warning Labels for Glyphosate
August 13, 2019Warning labels for the suspected cancer-causing weed killer glyphosate (Roundup) will not be approved by the U.S. Environmental Protection Agency. -
Roundup cancer verdict sends Bayer shares sliding
August 16, 2018Bayer's newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer.
Pharma Sources Insight January 2025
